Sanchez-de la Rosa R, Sabater E, Casado MA Cost analysis of glatiramer acetate vs. Fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain Health Econ Rev. 2013;3:13 doi:10.1186/2191-1991-3-13 MÁS INFORMACIÓN